New General USP Chapter <1210> on Statistical Tools for Procedure Validation
Recommendation

Thursday, 3 September 2026 9 .00 - 17.00 h
Establishment, Use and Maintenance of Analytical Reference Substances
In the Pharmacopoeial Forum 40(5) the In Process Revision of USP General Chapter <1210> - Statistical Tools for Procedure Validation has been announced.
This new chapter is seen as a complement to the chapter <1225> - Pharmacopoeial methods validation. The statistical procedures which are presented in <1210> are not only applicable for Pharmacopoeial procedures but for a variety of analytical methods, both for chemical def. APIs as well as for large biological molecules.
This comprehensive chapter introduces statistical methods that can be used during the validation of analytical methods. An analytical procedure is considered validated if it is shown that the performance characteristics are within required limits with stated confidence.
Specifically, this chapter covers the following analytical performance characteristics from a statistical point of view:
- Accuracy
- Precision
- Range
- Detection limit
- Quantitation limit
- Linearity
The USP proposal of the General Chapter <1210> - Statistical Tools for Procedure Validation is available in the Pharmacopoeial Forum.
Source: USP
Related GMP News
01.07.2026Several FDA Warning Letters and Untitled Letters on Asbestos Testing of Talc in OTC Drug Products
24.06.2026Analytical Quality Group Developments January through April 2026
17.06.2026BioPhorum Publishes a Roadmap for QC Sample Test Execution
03.06.2026EMA Provides an Outlook on the Product-Specific Bioequivalence Guidelines Expected in 2026
03.06.2026FDA Warning Letter: Missing Method Validation - From a QC Topic to a Market-Access Problem
28.05.2026WHO Working Document on Bioequivalence open for Public Consultation


